Skip to main content
89 search results for:

Colon cancer 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 13-04-2018 | Colon cancer | News | Article

    Adjuvant chemotherapy duration in stage III colon cancer: One size does not fit all

    The optimal duration of adjuvant chemotherapy in patients with stage III colon cancer may depend on the regimen used and the patient’s risk status, indicate the results of the international IDEA collaboration.

  2. 13-10-2017 | Colon cancer | News | Article
    News in brief

    Deficient MMR phenotype linked to favorable FOLFOX colon cancer DFS

    In patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy, DNA mismatch repair deficiency is associated with longer disease-free survival than MMR proficiency, confirms a pooled analysis published in JAMA Oncology .

  3. 08-05-2017 | Colonoscopy | News | Article

    Colonoscopy delays may not increase cancer risk

    Delaying follow-up colonoscopy for up to 10 months after a positive fecal immunochemical test is not associated with a significantly increased risk for colorectal cancer and more advanced disease, US study data show.

  4. 22-09-2023 | KRAS inhibitors | News | Article

    Novel KRAS inhibitor elicits ‘durable responses’ in KRAS G12C mutation-positive tumors

    They were aged a median of 65 years and 60 had non-small-cell lung cancer (NSCLC), while 55 had colorectal cancer (CRC) and 22 had other solid tumors.

  5. 31-10-2017 | Colorectal cancer | Article

    Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis

    Dubé C et al. Am J Gastroenterol 2017; 112: 1790–1801. doi:10.1038/ajg.2017.360

  6. 26-01-2017 | Colorectal cancer | Article

    The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis

    This meta-analysis demonstrates that patients with right-sided colorectal cancer (CRC) have significantly worse overall survival than those with left-sided CRC. Yahagi M et al. J Gastrointest Surg 2016; 20: 648–655. doi:10.1007/s11605-015-3026-6

  7. 06-01-2015 | Colorectal cancer | Article

    Robotic surgery for colon and rectal cancer

    Park EJ & Baik SH. Curr Oncol Rep 2016; 18: 5. doi:10.1007/s11912-015-0491-8

  8. 13-07-2022 | Immunotherapy | News | Article

    ICI therapy feasible in advanced cancer patients with kidney transplant using immunosuppression

    Discontinuation of immunosuppressive therapy may not be required for patients with a kidney transplant receiving immune checkpoint inhibitor therapy for advanced cancer, indicates preliminary research published in The Lancet Oncology .

  9. 06-06-2022 | ASCO 2022 | Conference coverage | Article

    Acetaminophen may blunt ICI response in people with cancer

    French researchers have identified an association between detectable plasma levels of acetaminophen and poor outcomes in people receiving immune checkpoint inhibitors for advanced cancer.

  10. 20-02-2022 | ASCO GU 2022 | Conference coverage | Article

    ​​​​​​​Sacituzumab govitecan–pembrolizumab combo encouraging for pretreated mUC

    Combination treatment with sacituzumab govitecan plus pembrolizumab has encouraging efficacy in metastatic urothelial cancer patients who have progressed on platinum-based therapy, report the TROPHY-U-01 researchers. This independent news story was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

  11. 14-10-2021 | COVID-19 | News | Article

    Cancer surgery systems need strengthening against future societal lockdowns

    Data form the international COVIDSurg collaborative study show that around one in seven patients did not undergo planned surgery for cancer if their region was in full COVID-19 lockdown.

  12. 01-10-2021 | EMA | News | Article
    approvalsWatch

    EMA supports extension of pembrolizumab use for advanced TNBC

    The positive opinion in this setting adds to the recommended use of pembrolizumab in patients with melanoma, non-small-cell lung cancer, classical Hodgkin lymphoma, urothelial cancer, head and neck squamous cell carcinoma, renal cell carcinoma, esophageal or gastroesophageal junction adenocarcinoma, and cancer of the colon or rectum. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

  13. 10-09-2021 | WCLC 2021 | Conference coverage | Article

    No OS benefit of lurbinectedin plus doxorubicin in relapsed SCLC

    The ATLANTIS trial has found no significant overall survival improvement with the combination of lurbinectedin and doxorubicin versus chemotherapy in previously treated patients with small-cell lung cancer.

  14. 12-05-2021 | COVID-19 | News | Article

    COVID-19 leaves large cancer screening deficit in USA

    Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.

  15. 05-03-2021 | COVID-19 | News | Article

    Marked dip in cancer screens at start of COVID-19 outbreak

    The early months of the COVID-19 pandemic saw a steep reduction in the number of people undergoing cancer screening tests, although numbers recovered subsequently, suggest data from northeastern USA.

  16. 22-12-2020 | Oligometastases | News | Article

    SBRT favorable for extracranial oligometastases

    Patients with a primary tumor in the prostate had the longest OS with the median not reached during the study period, followed by patients with tumors in the kidney at a median OS of 82 months, the breast at 51 months, the colon or rectum at 49 months, and the lung at 32 months, respectively.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.